Inocras Presents Poster for Breast Cancer at 2024 ASCO Annual Meeting, Showing Transformative Impact of WGS-based HRD Testing
Business Wire
SAN DIEGO--(BUSINESS WIRE)--Inocras Inc., a leader in whole genome sequencing (WGS) diagnostics and precision medicine, is proud to..